Expert Pitch

Desperate to reopen, Tesla risks workers safety

Cornell University
28-Apr-2020 11:25 AM EDT, by Cornell University

Tesla has backtracked on a plan to have some workers to return to work before San Francisco Bay area stay-at-home orders are scheduled to expire. The company, expected to report quarterly earnings on Wednesday, said production at its Fremont, California plant will not resume this week.

Arthur Wheaton, an expert on the automotive industry at Cornell University’s ILR School, says management is trying to save the company from bankruptcy, but opting for an early opening would be risky and possibly illegal.

Bio: https://www.ilr.cornell.edu/people/arthur-wheaton

Wheaton says: “Tesla is attempting to restart its production lines as soon as possible. Tesla, like all car manufacturers, is bleeding hundreds of millions or billions of dollars in lost revenue. It is not a silly idea to try to save the company from bankruptcy, but it is risky and possibly illegal.

“The Detroit Three (GM, Ford, FCA) workers are represented by the UAW and have collective bargaining agreements. Those contracts require discussion of health and safety issues between UAW and the company. Tesla, Honda, Kia, Hyundai, Toyota and pretty much all of the other car producers are not unionized in the U.S. and can unilaterally fire any employees at any time except for race, religion, gender or other federally protected civil rights.

“Tesla has already shown willingness to violate the law by keeping open beyond mandatory shut down and trying to open before stay-at-home orders are lifted. No production at Fremont means no cars or revenue for Tesla motors in the U.S. Tesla is desperate and arrogant and holds little regard for worker safety as shown in multiple OSHA violations.

“GM, Ford, and FCA would also love to open but they are taking a more well-thought-out approach and seeking employee feedback and suggestions for returning safely as state and local governments allow. Thousands of potential lives are at risk for workers, families and communities along with the economy costs to those same workers, families and communities.”

- 30 -

 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.50201